Tng adds that Venture could also thrive on customers having an additional impetus to diversify their manufacturing locations, even though this could be incrementally more expensive.
SINGAPORE (Feb 28): Despite the Covid-19 outbreak threatening to disrupt supply chains and introduce production bottlenecks and component shortages, analysts have identified opportunities for Venture Corporation to tap on during this period of trouble.
In a Thursday report, CGS-CIMB lead analyst William Tng says that Venture is poised to benefit from companies seeking alternative manufacturing partners with facilities outside China to help them tide over the current situation, which could in turn provide new revenue streams for the company even after the resolution of the virus outbreak.
